Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions.

Rasoanaivo P, Wright CW, Willcox ML, Gilbert B. · 2011

Read Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions. by Rasoanaivo P, Wright CW, Willcox ML, Gilbert B. (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3059462.txt.

Introduction

Rasoanaivo, Wright, Willcox, and Gilbert reviewed in 2011 why whole plant extracts often beat their single purified ingredients against malaria. Traditional healers use whole plants or mixtures, and crude extracts repeatedly outperform isolated compounds at the same dose in lab and animal tests. The review sorts the kinds of teamwork between plant chemicals that could explain the gap.

Some ingredient pairs attack the parasite together more strongly than either alone, a pattern shown for the bark alkaloids behind quinine. Other ingredients speed absorption, so a tea delivers its active drug faster than the pure drug alone. Some extracts also calm the immune side effects or block the parasite's drug resistance pumps. Ginger style additions are sometimes there just to ease nausea. The authors call for clinical trials of both purified combinations and traditional mixtures, especially for remote areas.

Catalog record

CREATORRasoanaivo P, Wright CW, Willcox ML, Gilbert B.
YEAR2011
COLLECTIONPAPERS
FORMATTXT
FILE SIZE57 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3059462

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions By Philippe Rasoanaivo, Colin W Wright, Merlin L Willcox, Ben Gilbert Published in: Malaria Journal DOI: 10.1186/1475-2875-10-S1-S4 ABSTRACT Background In traditional medicine whole plants or mixtures of plants are used rather than isolated compounds. There is evidence that crude plant extracts often have greater in vitro or/and in vivo antiplasmodial activity than isolated constituents at an equivalent dose. The aim of this paper is to review positive interactions between components of whole plant extracts, which may explain this. Methods Narrative review. Results There is evidence for several different types of positive interactions between different components of medicinal plants used in the treatment of malaria. Pharmacodynamic synergy has been demonstrated between the Cinchona alkaloids and between various plant extracts traditionally combined. Pharmacokinetic interactions occur, for example between constituents of Artemisia annua tea so that its artemisinin is more rapidly absorbed than the pure drug. Some plant extracts may have an immunomodulatory effect as well as a direct antiplasmodial effect. Several extracts contain multidrug resistance inhibitors, although none of these has been tested clinically in malaria. Some plant constituents are added mainly to attenuate the side-effects of others, for example ginger to prevent nausea. Conclusions More clinical research is needed on all types of interaction between plant constituents. This could include clinical trials of combinations of pure compounds (such as artemisinin + curcumin + piperine) and of combinations of herbal remedies (such as Artemisia annua leaves + Curcuma longa root + Piper nigum seeds). The former may enhance the activity of existing pharmaceutical preparations, and the latter may improve the effectiveness of existing herbal remedies for use in remote areas where modern drugs are unavailable. BACKGROUND Over 1,277 plants belonging to 160 families were reported in 2004 to be used traditionally for the treatment of malaria following an extensive survey of the literature [1], and since then the number of species has increased substantially due to the increasing worldwide interest in anti-malarial plants. In traditional practice, several plants are often used in combination. Some of them have been screened as crude extracts for in vitro and/or in vivo anti-plasmodial activity directed to the erythrocytic stage of malaria parasites. Single active anti-plasmodial constituents have been successfully characterized from some extracts, following the pharmaceutical industry paradigm of drug discovery [2-4]. In other cases, it has not been possible to isolate active constituents from active extracts. Several explanations have been proposed for this, such as the poor quality of ethnopharmacological studies, plant material processing, preclinical laboratory protocols which are often very different from local practices, an inadequate fractionation process, degradation of active constituents during fractionation and poor biological models to demonstrate activities. Nevertheless one hypothesis that has not been extensively exploited in conventional anti-malarial therapy is synergistic interaction or multi-factorial effects between compounds present in herbal extracts [5,6]. The principal synergistic combination anti-malarials currently produced are Malarone® (atovaquone-proguanil)[7] and Quinimax® (quinine-quinidine-cinchonine)[8,9]. Pure drugs that are industrially produced or isolated from plants may be chosen for their high activity against a human disease, but they have disadvantages. They rarely have the same degree of activity as the unrefined extract at comparable concentrations or dose of the active component [10]. This phenomenon is attributed to the absence of interacting substances present in the extract. Furthermore, many plants contain substances that inhibit multi-drug resistance (MDR). A further disadvantage is that pure drugs are often more expensive to produce and distribute, and so are often unavailable and/or unaffordable to the poorest populations in remote areas who need them most. In contrast, herbal medicines can sometimes be grown and produced locally, at lower cost, by or close to those who need them [11]. The aim of this paper is to review positive interactions between components of whole plant extracts, which may explain why crude extracts are often more effective than isolated constituents at an equivalent dose. In some cases this has been exploited in the making of combined drugs. However, it is possible that a valid complementary approach is the use of standardized crude herbal medicines and/or combinations for the treatment of malaria, if their safety and efficacy are clinically demonstrated. THE NOTION OF SYNERGY – EVOLUTIONARY BASIS AND MECHANISMS Plants survive in a hostile environment of predatory micro- and macro-organisms in part by tough and durable external structures and by rapid growth and reproduction, but their main defences are chemical. Defensive chemicals may be present at all or certain periods of growth, and in determined locations in the plant, they may be generated after a predatory attack has been inflicted or they may be exuded into the air or soil [12]. In contrast to animals, plants do not have an adaptive immune system, so their chemical shield must cover completely the entire spectrum of macro- and micro-organisms that exist in their natural habitat and endanger their existence. However it must be recognized that groups of species growing in proximity often contribute to a collective shield [12]. The chemical defence is largely made up of relatively small molecules that fit into sites in enzymes or receptors of the predator interfering with its life processes. Over time, the attacking organisms often develop resistance to the plant’s defences, and plants co-evolve to produce resistance inhibitors [13], resulting in a great complexity of phytochemicals in every species. Indeed if plants followed the pharmaceutical model of producing only a single compound against microorganisms which threaten them, they would probably not survive for very long. Metabolic processes in animal parasites are often mediated by enzymes and receptor molecules that possess sites which will accommodate the plant chemical defence substances, so it is not surprising that these plant defences may also serve against agents of animal diseases such as malaria. In many cases there is evidence of synergy, but the exact mechanisms have not been elucidated. Several mechanisms may also be operating in parallel. For example Artemisia annua (Asteraceae) is now one of the best known anti-malarial plants [14]. The use of herbal teas prepared from the dried leaves of locally grown A. annua is being promoted as an alternative treatment for malaria in areas where people do not have access to, or cannot afford effective anti-malarials such as artemisinin combination therapy [11]. In a recent study, extracts were obtained from fresh A. annua herb either by soaking the herb in water followed by wringing out the juice by hand or by pounding the fresh herb to a pulp followed by squeezing out the juice [15]. The extracts were then analysed for artemisinin concentration and tested against malaria parasites. It was found that the anti-plasmodial IC50 values were 6 to 18-fold lower than was expected in terms of their artemisinin content suggesting that the activity of the extracts could not be accounted for entirely by their artemisinin content. In mice infected with Plasmodium berghei, the pounded juice (two doses of 500 μL, 12 h apart) equivalent to 18 mg/kg artemisinin suppressed parasitaemia by 95% compared with artemisinin 30 mg/kg as a single dose which suppressed parasitaemia by 88% [15]. In mice infected with P. berghei given a crude ethanolic extract of A. annua formulated with oil in a soft gel capsule,

Read the complete text